| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |